These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30427656)

  • 1. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
    Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
    ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Davies DT; Leiris S; Sprynski N; Castandet J; Lozano C; Bousquet J; Zalacain M; Vasa S; Dasari PK; Pattipati R; Vempala N; Gujjewar S; Godi S; Jallala R; Sathyap RR; Darshanoju NA; Ravu VR; Juventhala RR; Pottabathini N; Sharma S; Pothukanuri S; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Mangani S; Docquier JD; Lemonnier M; Everett M
    ACS Infect Dis; 2020 Sep; 6(9):2419-2430. PubMed ID: 32786279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-
    Lee T; Lee S; Kim MK; Ahn JH; Park JS; Seo HW; Park KH; Chong Y
    ACS Infect Dis; 2024 May; 10(5):1624-1643. PubMed ID: 38652574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae.
    Lee YR; Baker NT
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1411-1419. PubMed ID: 29675787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens
    Samuelsen Ø; Åstrand OAH; Fröhlich C; Heikal A; Skagseth S; Carlsen TJO; Leiros HS; Bayer A; Schnaars C; Kildahl-Andersen G; Lauksund S; Finke S; Huber S; Gjøen T; Andresen AMS; Økstad OA; Rongved P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
    Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
    J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing
    Asempa TE; Motos A; Abdelraouf K; Bissantz C; Zampaloni C; Nicolau DP
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Cisplatin and Palladium(II) Complexes as Potent Metallo-β-lactamase Inhibitors for Targeting Carbapenem-Resistant
    Chen C; Sun LY; Gao H; Kang PW; Li JQ; Zhen JB; Yang KW
    ACS Infect Dis; 2020 May; 6(5):975-985. PubMed ID: 32119777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
    Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
    Davies DT; Everett M
    Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
    Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
    Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
    J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
    Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
    Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.